Back
Consumer News

NVISION® Eye Centers Becomes One of the First in the U.S. to Offer Breakthrough KAMRA Inlay for Near Vision Loss Associate with Aging

April 15, 2015

NVISION® Founder Served as Principle Investigator in Clinical Trials Resulting in FDA Approval of Revolutionary Procedure to Correct Presbyopia

ALISO VIEJO, CA (Apr. 1, 2015)NVISION® Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S., is pleased to announce it will be one the first in the U.S. to provide the revolutionary KAMRA® inlay procedure designed to treat presbyopia, a condition causing the loss of near vision that affects nearly everyone over the age of 40. Dr. Tom Tooma, NVISION® founder and LASIK pioneer, was a principle investigator in the clinical trials that after a decade of research, development and investigation have resulted in the recent U.S. FDA approval of this long-awaited groundbreaking treatment.

“NVISION® is extremely proud to be among the dedicated group of researchers who have spent years working to bring this innovative technology to the forefront of American ophthalmology,” says Dr. Tooma, underscoring the significance of participating in the clinical trials. “Not only are we proud to be one of the first in the US to offer this life-changing procedure but also tremendously grateful to the patients who placed their unwavering trust in us during all stages of the trials, enabling NVISION® to gain deep knowledge and expertise that very few can claim.”

Developed by AcuFocus, Inc., the Irvine, Calif.-based global leader in corneal inlay technology, the KAMRA inlay is a first-of-its-kind outpatient procedure performed in approximately 15 minutes. Implanted in a pocket within the cornea, the KAMRA inlay relies on small aperture optics designed to increase depth-of-focus. Smaller and thinner than a contact lens, the KAMRA inlay—previously available in more than 40 countries outside the U.S. and implanted more than 20,000 times worldwide—is the first U.S. FDA-approved procedure that can restore near vision without compromising distance vision.

According to the American Academy of Ophthalmology, more than 1 billion people worldwide suffer from presbyopia, a decrease in near vision due to the natural aging of the internal lens of the eye. Research estimates more than 114 million people are affected in the U.S., including the entire Baby Boomer generation. By 2020, that number is expected to grow to more than 123 million, as Americans in their 40s and 50s begin to experience the frustration and difficulty of reading up close and performing near tasks.

“Up until now, options for patients in the U.S. with near vision loss have been limited to reading glasses, bifocals or surgical procedures that compromise patients’ distance vision and offer no guarantee of lasting success,” says James Pereyra, President of NVISION®. “Breakthroughs like this have the power to change lives. With the KAMRA inlay, NVISION® can continue—with great confidence—our mission to improve vision with the safest and most effective solutions that are proven to bring clarity of sight and pave the way for a brighter future.”

NVISION® doctors are among the most distinguished, experienced and educated surgeons in the laser vision correction industry committed to providing the latest, most sophisticated technologies in diagnostics and surgical procedures. In fact, five of NVISION®’s centers have been selected as “Centers of Excellence” by AcuFocus for the launch of the KAMRA inlay. This means NVISION® surgeons will help expand the technology throughout the U.S. by training other ophthalmologists in the procedure. NVISION® doctors have participated in numerous clinical trials and have trained more than 1,900 eye doctors throughout California, Nevada and Oregon providing the latest cutting-edge technologies to assist them in recognizing those patients who could benefit from LASIK, cataract and now KAMRA inlay procedures.

ABOUT NVISION® EYE CENTERS: NVISION® Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION® is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION® was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 100,000 procedures throughout his esteemed career. With more than 1,900 eye doctors referring their patients and trusting their own eyes to NVISION® surgeons, NVISION® Eye Centers is the Eye Doctors' #1 Choice®.

For more information, visit www.NVISIONCenters.com or call (877) 455-9942.